Trisomy 13, nonmosaicism (meiotic nondisjunction) is a rare genetic disorder that occurs when a person has an extra copy of chromosome 13 in their cells. This condition is also known as Patau syndrome. It is caused by a random error in cell division during the formation of eggs or sperm, resulting in an extra chromosome 13.
Trisomy 13 affects approximately 1 in 10,000 to 1 in 16,000 live births. It is characterized by a wide range of physical and intellectual disabilities. Babies born with Trisomy 13 often have various birth defects, including cleft lip and palate, heart abnormalities, polydactyly (extra fingers or toes), and severe intellectual disabilities.
Here are some key features of Trisomy 13:
Trisomy 13 is a life-limiting condition, and the majority of affected individuals do not survive beyond the first year of life. However, with advances in medical care, some individuals with Trisomy 13 can live into their teenage years or early adulthood.
It is important to note that Trisomy 13 cannot be treated or cured. Medical care for individuals with this condition focuses on managing the associated health problems and providing supportive care to improve their quality of life.
In conclusion, Trisomy 13, nonmosaicism (meiotic nondisjunction) is a rare genetic disorder caused by an extra copy of chromosome 13. It is associated with a range of physical and intellectual disabilities. Although there is no cure for Trisomy 13, medical interventions can help improve the quality of life for affected individuals.
Trisomy 13, nonmosaicism, also known as meiotic nondisjunction, is a rare genetic condition characterized by the presence of an extra chromosome 13. This condition can lead to various physical and developmental abnormalities, making it crucial to explore treatment options. While there is no cure for Trisomy 13,...
To see full information about treatment please Sign up or Log in